Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teh Seng Pharmaceutical Mfg CoROCO:7860 +4.35%23 ROE % is 12.90% as of Dec. 2025, which is 12% above its 10-year median of 11.52. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review. Among 937 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks better than 62.97% on this metric.
The historical rank and industry rank for Teh Seng Pharmaceutical Mfg Co's ROE % or its related term are showing as below:
ROCO:7860'
s ROE % Range Over the Past 10 Years
Min: 9.42 Med: 11.52 Max: 17.29
Current: 9.57
During the past 3 years, Teh Seng Pharmaceutical Mfg Co's highest ROE % was 17.29%. The lowest was 9.42%. And the median was 11.52%.
ROCO:7860's ROE % is ranked better than 62.97% of 937
companies
in the Drug Manufacturers industry
Industry Median: 6.06
vs ROCO:7860: 9.57
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Teh Seng Pharmaceutical Mfg Co ROE % Related Terms
Teh Seng Pharmaceutical Mfg Co ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co ROE % Chart
Teh Seng Pharmaceutical Mfg Co Annual Data
Trend
Dec23
Dec24
Dec25
ROE %
11.52
17.29
9.42
Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
ROE %
0.00
13.52
20.65
6.33
12.90
ROCO:7860 vs ZTS, UTHR: ROE % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teh Seng Pharmaceutical Mfg Co ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's ROE % distribution charts can be found below:
* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a ROE % of 12.90% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. This is 12% above median its historical median of 11.52. Over the past decade, Teh Seng Pharmaceutical Mfg Co's ROE % has ranged from 9.42 to 17.29. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #347 out of 937 companies in the Drug Manufacturers industry, placing it in the top 37%.
Is Teh Seng Pharmaceutical Mfg Co's ROE % too high?
Teh Seng Pharmaceutical Mfg Co's current ROE % of 12.90% is 12% above median its 10-year median of 11.52. Over the past 10 years, this metric has ranged from a low of 9.42 to a high of 17.29. The Drug Manufacturers industry median ROE % is 6.06. Teh Seng Pharmaceutical Mfg Co's value of 12.90% is 112.9% above this industry median. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #347 out of 937 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #347 out of 937 companies for ROE %. This puts Teh Seng Pharmaceutical Mfg Co in the upper half of its industry. The industry median ROE % is 6.06. Teh Seng Pharmaceutical Mfg Co's value of 12.90% is 112.9% above this benchmark. Historically, Teh Seng Pharmaceutical Mfg Co's own ROE % has ranged from 9.42 to 17.29 over the past decade. While the company's 10-year median is 11.52 vs. the industry median of 6.06, Teh Seng Pharmaceutical Mfg Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.06, based on 937 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teh Seng Pharmaceutical Mfg Co's current ROE % of 12.90% is 112.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current ROE % is 12.90%, which is 12% above median its own 10-year median of 11.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current ROE % of 12.90%. The current ROE % is 12.90%, which is 12% above median its 10-year median of 11.52 and 112.9% above the Drug Manufacturers industry median of 6.06. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current ROE % is 12.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Business Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score
Get the complete analysis for ROCO:7860
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
